BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32447239)

  • 1. Predictors of drug-resistance in epilepsy with auditory features.
    Zhang L; Zhu X; Peng A; Lai W; He S; Qiu X; Zou X; Chen L
    Epilepsy Res; 2020 Aug; 164():106353. PubMed ID: 32447239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug resistance in adult patients with generalized epilepsy: A case-control study.
    Voll A; Hernández-Ronquillo L; Buckley S; Téllez-Zenteno JF
    Epilepsy Behav; 2015 Dec; 53():126-30. PubMed ID: 26561950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies.
    Gesche J; Khanevski M; Solberg C; Beier CP
    Epilepsia; 2017 Apr; 58(4):e64-e69. PubMed ID: 28230254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients with refractory idiopathic generalized epilepsy.
    Gomez-Ibañez A; McLachlan RS; Mirsattari SM; Diosy DC; Burneo JG
    Epilepsy Res; 2017 Feb; 130():69-73. PubMed ID: 28157601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
    Sheikh SR; Thompson N; Frech F; Malhotra M; Jehi L
    Epilepsia; 2020 Aug; 61(8):1627-1637. PubMed ID: 32658343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
    Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L
    JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of carbamazepine and oxcarbazepine in the management of epilepsy.
    Beydoun A; DuPont S; Zhou D; Matta M; Nagire V; Lagae L
    Seizure; 2020 Dec; 83():251-263. PubMed ID: 33334546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis.
    Faught E; Helmers S; Thurman D; Kim H; Kalilani L
    Epilepsy Behav; 2018 Aug; 85():37-44. PubMed ID: 29906700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized onset seizures with focal evolution (GOFE) - A unique seizure type in the setting of generalized epilepsy.
    Linane A; Lagrange AH; Fu C; Abou-Khalil B
    Epilepsy Behav; 2016 Jan; 54():20-9. PubMed ID: 26619379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to first antiseizure medication in patients diagnosed with epilepsy.
    Hersi H; Saarinen JT; Raitanen J; Peltola J
    Acta Neurol Scand; 2021 Jul; 144(1):67-75. PubMed ID: 33835491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.
    Söylemez E; Öztürk O; Baslo SA; Balçık ZE; Ataklı D
    Epilepsy Behav; 2020 Oct; 111():107296. PubMed ID: 32769040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center.
    Cerulli Irelli E; Morano A; Barone FA; Fisco G; Fanella M; Orlando B; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Epilepsia; 2020 Nov; 61(11):2452-2460. PubMed ID: 33345323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
    Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
    Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting uncontrolled seizures in epilepsy with auditory features.
    Zhang L; Zhu X; Zou X; Chen L
    Seizure; 2019 Feb; 65():55-61. PubMed ID: 30612076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative seizure outcome and timing interval to start antiepileptic drug withdrawal: A retrospective observational study of non-neoplastic drug resistant epilepsy.
    Zhang L; Jiang XY; Zhou D; Zhang H; Bao SM; Li JM
    Sci Rep; 2018 Sep; 8(1):13782. PubMed ID: 30213952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of unfavourable seizure outcome in patients with epilepsy in Nepal.
    Lohani S; Devkota UP; Rajbhandari H
    Can J Neurol Sci; 2010 Jan; 37(1):76-80. PubMed ID: 20169777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.